Drug interactions with vitamin c
Pro Research Analysisby 
Searched over 200M research papers
Drug Interactions with Vitamin C
Opioids and Vitamin C: Redox-Signaling Crosstalk
Opioids, widely used for pain management, can cause severe side effects such as central respiratory depression and systemic hypoxia, leading to free radical generation. Vitamin C (ascorbic acid, AA), a potent antioxidant, has been shown to mitigate some of these adverse effects. The interaction between opioids and vitamin C involves complex signaling pathways. Vitamin C can neutralize reactive oxygen and nitrogen species produced by opioids, but this alone does not fully explain the observed benefits. Further research is needed to understand how vitamin C influences downstream signaling pathways like STAT3, HIF1α, and NF-κB, which are involved in the production of antioxidant proteins .
Vitamin C and Drug Metabolism
Vitamin C can influence drug metabolism and vice versa. For instance, tetracycline has been shown to reduce leucocyte ascorbic acid concentrations, possibly by interfering with intracellular metabolism. This interaction highlights the need for further studies to understand how vitamin C affects the pharmacological actions of various drugs and how drugs can alter vitamin C synthesis and function within the body .
High-Dose Intravenous Vitamin C: Safety and Adverse Effects
High-dose intravenous (IV) vitamin C is commonly used by Complementary and Alternative Medicine (CAM) practitioners for various conditions, including infections and cancer. While generally considered safe, high doses can lead to adverse effects such as oxalate nephropathy, hypernatremia, hemolysis in glucose-6-phosphate dehydrogenase deficiency patients, and kidney stones. Despite these risks, the overall safety profile of high-dose IV vitamin C appears favorable, but specific monitoring is recommended for at-risk populations 34.
Vitamin C and Antineoplastic Drugs
Vitamin C can antagonize the cytotoxic effects of antineoplastic drugs like doxorubicin, cisplatin, vincristine, methotrexate, and imatinib. Pretreatment with vitamin C has been shown to reduce the therapeutic efficacy of these drugs in leukemia and lymphoma cell lines by preserving mitochondrial membrane potential and decreasing apoptosis. This suggests that vitamin C supplementation during cancer treatment may negatively impact therapeutic outcomes, warranting caution in its concurrent use with antineoplastic agents .
Vitamin C and Citalopram-Induced Testicular Toxicity
Citalopram, an antidepressant, can impair spermatogenesis and male fertility. Vitamin C has been found to counteract these adverse effects by improving sperm parameters, testosterone levels, and testicular histopathology. It achieves this by reducing nitro-oxidative stress and apoptosis in testicular cells, suggesting that vitamin C could be a beneficial adjunct therapy for mitigating reproductive toxicity associated with antidepressant use .
Vitamin C in Kidney Transplantation
Kidney transplant recipients often suffer from vitamin C deficiency, which is linked to higher mortality rates. Vitamin C supplementation in these patients can improve endothelial function and creatinine clearance. However, it is essential to monitor for potential side effects such as kidney stones, hemolysis in glucose-6-phosphate dehydrogenase deficiency patients, and interactions with medications like cyclosporine. Vitamin C can also interfere with creatinine assays, necessitating careful consideration in clinical settings .
Conclusion
Vitamin C interacts with various drugs, influencing their metabolism, efficacy, and safety profiles. While it offers potential benefits in mitigating side effects and improving health outcomes, its interactions with medications, particularly antineoplastic drugs and those used in kidney transplantation, require careful monitoring and further research. Understanding these interactions can help optimize therapeutic strategies and improve patient care.
Sources and full results
Most relevant research papers on this topic